Cycle 1 (Predose)a | Cycle 2 | Cycle 3 | Cycle 4 | Cycle 5 | Cycle 6 | Cycle 7 | EOT |
---|---|---|---|---|---|---|---|
Patients with relapsed or refractory ALL who received single-agent InOb | |||||||
x | Â | Â | x | Â | Â | Â | x |
x | x | x | x | x | x | Â | x |
Patients with relapsed or refractory NHL who received single-agent InOc | |||||||
x | x | x | x | x | Â | x | x |
x | x | x | x | x | Â | x | x |
x | Â | x | Â | Â | Â | Â | x |
Patients with relapsed or refractory NHL who received InO plus rituximabc | |||||||
 | x | x | x | x |  | x | x |
 | x | x | x | x |  | x | x |
x | Â | Â | Â | Â | Â | Â | Â |
x | Â | Â | x | Â | Â | Â | x |
x | x | x | x | x | x | Â | x |
Patients with relapsed or refractory NHL who received InO plus rituximab plus chemotherapyc | |||||||
x | Â | Â | x | Â | Â | Â | x |